Reckitt Benckiser Group plc Sponsored ADR (RBGLY)
How a Western Consumer Giant Is Thriving on China's Social-Media Shoppers
A change in Reckitt's sales tactics led to 12 consecutive quarters of double-digit sales growth in the country.
Reckitt faces mixed broker forecasts ahead of third-quarter update
Reckitt Benckiser Group PLC (LSE:RKT, OTCQX:RBGLY), the consumer health and hygiene company, faces differing forecasts from UBS and Jefferies ahead of its third-quarter trading update, with both brokers retaining ‘buy' ratings but taking different views on near-term growth. UBS expects group like-for-like sales growth of 3.7% in the third quarter, broadly in line with Visible Alpha consensus, while Core Reckitt is forecast to grow 4.2%, matching the rate reported in the second quarter.
Reckitt Benckiser Group plc (RBGLY) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Reckitt Benckiser Group plc (RBGLY) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
I rate Reckitt Benckiser a buy with a 12–24 month horizon and medium confidence, citing a 21% discount to peer multiples despite litigation overhang. Core Reckitt delivers high-margin, volume-led growth, with FY2025 organic growth of +5.2% and a 26.7% adjusted operating margin, supporting quality business status. Mead Johnson litigation risk remains the key discount driver; recent favorable legal outcomes improve sentiment but do not resolve federal MDL exposure.
Reckitt Benckiser Group: A Solid Quarter Supports The Investment Case
Reckitt delivered solid H1 results, with top line growth in both Core Reckitt and Mead Johnson Nutrition, despite regional disparities. RBGLY's operating profit, margin, and cash flow fell, mainly due to the Essential Home divestment, but management remains confident about forward momentum. The interim dividend grew 5% to 88.6p, yielding 4.2%, and a new £500m buyback was announced, signaling ongoing capital returns.
Reckitt Benckiser Group H1 Earnings Call Highlights
Reckitt Benckiser Group LON: RKT reported accelerating sales growth in the second quarter of 2026, supported by innovation, emerging-market demand and a return to growth in North America, while maintaining its full-year outlook despite commodity and supply-chain volatility.
Lysol Maker Reckitt Issues New $664 Million Share Buyback
The Lysol, Mucinex and Durex-condom maker issued a new share buyback program after reporting 4.7% like-for-like net revenue, bolstered by growth in emerging markets.
Lysol Maker Reckitt to Offload Sanctions-Hit Russian Hygiene Business
The deal with Russia's Arnest Management—which manufactures cosmetics and household goods—is expected to complete during the second half of 2026.
Jefferies upgrades Reckitt to buy, arguing market has over-punished transitory setbacks
Jefferies has upgraded Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB)to 'buy' from 'hold', raising its price target to 5,900p from 5,600p ahead of half-year results next week. The broker argues the market has overly discounted a run of setbacks that hit the consumer goods group in early 2026, most of which it classes as one-off and unlikely to recur beyond this year.
Reckitt Benckiser: Cheap Again, I'm Going In
Reckitt Benckiser is experiencing a market overreaction to the downside, creating an attractive entry point below £46/share. RBGLY's recent share price decline is driven by temporary macro headwinds—oil price sensitivity and a weak cold/flu season—not by fundamental business weakness. I have rebased my valuation to a 15x P/E multiple, lowering my price target to £46/share, and now rate the stock a 'Buy.'
Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth
Reckitt Benckiser Group LON: RKT executives used an investor “Focus On” event to outline how the company is applying digital science, artificial intelligence and predictive modeling across its innovation process, saying the capabilities are intended to support faster product development, stronger launch execution and efficiency gains.
Reckitt Benckiser Group plc (RBGLY) Q1 2026 Sales/Trading Call Transcript
Reckitt Benckiser Group plc (RBGLY) Q1 2026 Sales/Trading Call Transcript
